This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Stéphanie Roy: Innovator in Antibiotic Development
Introduction
Stéphanie Roy is a notable inventor based in Lachine, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. Her work focuses on creating innovative solutions to combat bacterial infections.
Latest Patents
Stéphanie Roy holds a patent for "Macrocyclic broad spectrum antibiotics." This patent describes antibacterial compounds that exhibit broad spectrum bioactivity. In various embodiments, the compounds act by inhibiting bacterial type 1 signal peptidases SpsB and/or LepB, which are essential proteins in bacteria. The patent also includes pharmaceutical compositions and methods for treatment using these compounds.
Career Highlights
Stéphanie Roy is associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work at Genentech has allowed her to contribute to groundbreaking research in antibiotic development.
Collaborations
Throughout her career, Stéphanie has collaborated with esteemed colleagues, including Claudio F Sturino and Guillaume Pelletier. These collaborations have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Stéphanie Roy's contributions to antibiotic development highlight her role as an innovator in the pharmaceutical field. Her patent for macrocyclic broad spectrum antibiotics represents a significant advancement in the fight against bacterial infections.